Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis

Lancet Infectious Diseases

Volumn 7, Issue 3, 2007, Pages 210-217

  Tang, Benjamin MP ^a,b   Eslick, Guy D ^b,c   Craig, Jonathan C ^b   McLean, Anthony S ^a  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROCALCITONIN;

CLASSIFICATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMBASE; HUMAN; MEDLINE; META ANALYSIS; PERFORMANCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REVIEW; SACKETT AND HAYNES CLASSIFICATION; SAMPLE SIZE; SCISEARCH; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMATIC REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOLOGICAL MARKERS; CALCITONIN; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY MEDICAL SERVICES; HUMANS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33847056146     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(07)70052-X     Document Type: Review

References (86)

1. Martin G., Mannino D., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
2. Warren H. Strategies for the treatment of sepsis. N Engl J Med 336 (1997) 952-953
3. Parillo J., Parker M., Natanson C., et al. Septic shock: advances in the understanding of pathogenesis, cardiovascular dysfunctions, and therapy. Ann Intern Med 113 (1990) 227-242
4. Pittet D., Rangel-Frausto S., Li N., Tarara D., and Costigan M. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 21 (1995) 302-309
5. Kollef M., Sherman G., Ward S., and Fraser V. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
6. Bochud P.-Y., Glauser M., and Calandra T. Antibiotics in sepsis. Intensive Care Med 27 suppl 1 (2001) S33-S48
7. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 26 suppl 1 (2000) S64-S74
8. American College of Chest Physicians, and Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-874
9. Rangel-Frausto M., Pittet D., Costigan M., Hwang T., Davis C., and Wenzel R. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995) 117-123
10. Marshall J. Infection and the host septic response: implication for clinical trials of mediator antagonism. In: Vincent J.-L. (Ed). Yearbook of intensive care and emergency medicine (1994), Springer-Verlag, Berlin 3-13
11. Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274 (1995) 968-974
12. Young L. Gram-negative sepsis. In: Mandell G., Douglas R., and Bennet J. (Eds). Principles and practice of infectious diseases (1990), Churchill Livingstone, New York 611-636
13. Assicot M., Gendrel D., Carsin H., et al. High serum procalcitonin concentration in patients with sepsis and infection. Lancet 341 (1993) 515-518
14. Brunkhorst F., Wegscheider K., Forycki Z., and Brunkhorst R. Procalcitonin for early diagnosis and differentation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26 suppl 2 (2000) S148-S152
15. Aouifi A., Piriou V., Bastien O., et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28 (2000) 3171-3176
16. Al-Nawas B., Krammer I., and Shah P. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1 (1996) 331-333
17. Levy M., Fink M., Marshall J., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250-1256
18. Vincent J.-L. THE marker of sepsis?. Crit Care Med 28 (2000) 1226-1228
19. Lapillonne A., Basson E., Monneret G., Bienvenu J., and Salle B. Lack of specificity of procalcitonin for sepsis diagnosis in premature infant. Lancet 351 (1998) 1211-1212
20. Ruokonen E., Ilkka L., Niskanen M., and Takala J. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46 (2002) 398-404
21. Ugarte H., Silva E., Mercan D., De Mendonca A., and Vincent J.-L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27 (1999) 498-504
22. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 (2001) 396-402
23. Muller B., Becker K., Schachinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28 (2000) 977-983
24. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
25. Deville W., and Buntinx F. Guidelines for conducting systematic reviews of studies evaluating the accuracy of diagnostic tests. In: Knottnerus J. (Ed). The evidence base of clinical diagnosis. 1st edn. (2002), BMJ, London 145-165
26. Lijmer J., Mol B., Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282 (1999) 1061-1066
27. Whiting P., Rutjes A., Reitsma J., Bossuyt P., and Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3 (2003) 1-13
28. Whiting P., Rutjes A., Reitsma J., Bossuyt P., and Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 8 (2004) 1-264
29. Sackett D., and Haynes R. The architecture of diagnostic research. In: Knottnerus J. (Ed). The evidence base of clinical diagnosis. 1st edn. (2002), BMJ, London 19-38
30. Glas A., Lijmer J., Prins M., Bonsel G., and Bossuyt P. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56 (2003) 1129-1135
31. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
32. Moses L., Littenberg B., and Shapiro D. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytical approaches and some additional consideration. Stat Med 12 (1993) 1293-1316
33. Walter S. Properties of the summary receiver operating characteristics (SROC) curve for diagnostic test data. Stat Med 21 (2002) 1237-1256
34. Egger M., Davey S., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
35. Duval S., and Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000) 455-463
36. Giamarellos-Bourboulis E., Mega A., Grecka P., et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 28 (2002) 1351-1356
37. Chirouze C., Schuhmacher H., Rabaud C., et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 35 (2002) 156-161
38. Delevaux I., Andre M., Colombier M., et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann Rheum Dis 62 (2003) 337-340
39. Munoz P., Simarro N., Rivera M., Alonso R., Alcala L., and Bouza E. Evaluation of procalcitonin as a marker of infection in a nonselected sample of febrile hospitalized patients. Diagn Microbiol Infect Dis 49 (2004) 237-241
40. Stucker F., Herrmann F., Graf J.-D., Michel J., Krause K., and Gauazzi G. Procalcitonin and infection in elderly patients. J Am Geriatr Soc 53 (2005) 1392-1395
41. Geppert A., Steiner A., Delle-Karth G., Heinz G., and Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med 29 (2003) 1384-1389
42. Liaudat S., Dayer E., Praz G., Bille J., and Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 20 (2001) 524-527
43. Aalto H., Takala A., Kautiainen H., and Repo H. Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 23 (2004) 699-704
44. Caterino J., Scheatzle M., Forbes M., and D'Antonio J. Bacteremic elder emergency department patients: procalcitonin and white count. Acad Emerg Med 11 (2004) 393-396
45. Guven H., Altintop L., Baydin A., et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 20 (2002) 203-206
46. Bell K., Wattie M., Byth K., et al. Procalcitonin: a marker of bacteraemia is SIRS. Anaesth Intensive Care 31 (2003) 629-636
47. Brunkhorst F., Eberhard O., and Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 27 (1999) 2172-2176
48. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., and Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31 (2003) 1737-1741
49. Balci C., Sungurtekin H., Gurses E., Sungurtekin U., and Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 7 (2003) 85-90
50. Prucha M., Herold I., Zazula R., Dubska L., Kavka B., and Dosta M. A comparison of procalcitonin, interleukin-6 and C-reactive protein in differential diagnosis of patients with the septic syndrome treated at the intensive care units. Vnitr Lek 49 (2003) 541-547 (in Czech).
51. Kazda A., Valenta J., Brodska H., Stach Z., Hendl J., and Stritesky M. Procalcitonin in critically ill patients. Klin Biochem Metabol 13 (2005) 4-9 (in Czech).
52. Hergert M., Lestin H.-G., Scherkus M., et al. Procalcitonin in patients with sepsis and polytrauma. Clin Lab 44 (1998) 659-670
53. Castelli G., Pognani C., Meisner M., Stuani A., Bellomi D., and Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8 (2004) R234-R242
54. Clec'h C., Ferriere F., Karoubi P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32 (2004) 1166-1169
55. Reith H., Mittelkotter U., Wagner R., and Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 26 (2000) S165-S169
56. Aikawa N., Fujishima S., Endo S., et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11 (2005) 152-159
57. Baumgarten R., Pequeriaux N., Van Puyenbroek M., and Speelberg B. Diagnosis of sepsis by procalcitonin. Ned Tijdschr Klin Chem 27 (2002) 32-35
58. Chan Y., Tseng C., Tsay P., Chang S., Chiu T., and Chen J. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 8 (2004) R12-R20
59. Cheval C., Timsit J., Garrouste-Orgeas M., et al. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Intensive Care Med 26 suppl 2 (2000) S153-S158
60. Du B., Pan J., Cheng D., and Li Y. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin. Chin Med J 116 (2003) 538-542
61. Hausfater P., Garric S., Ayed B., Rosenheim M., Bernard M., and Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34 (2002) 895-901
62. Mokart D., Merlin M., Sannini A., et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94 (2005) 767-773
63. Selberg O., Hecker H., Martin M., Klos A., Bautsch W., and Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28 (2000) 2793-2798
64. Suprin E., Camus C., Gacouin A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 26 (2000) 1232-1238
65. Tugrul S., Esen F., Celebi S., et al. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth Intensive Care 30 (2002) 747-754
66. Wanner G., Keel M., Steckholzer U., Beier W., Stocker R., and Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28 (2000) 950-957
67. Bossink A., Groeneveld A., and Thijs L. Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 29 (1999) 398-407
68. Gibot S., Kolopp-Sarda M.-N., and Bene M.-C. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141 (2004) 9-15
69. Tatsioni A., Zarin D., Aronson N., Samson D., et al. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 142 (2005) 1048-1055
70. Nierenberg A., and Feinstein A. How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppresion test. JAMA 259 (1988) 1699-1702
71. Jenicek M. Identifying cases of disease. Clinimetrics and diagnosis. In: Jenicek M. (Ed). Foundations of evidence-based medicine (2003), Parthenon, London 107-146
72. Jaeschke R., Guyatt G., and Sackett D. User's guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271 (1994) 703-707
73. Deeks J. Systematic reviews of evaluations of diagnostic and screening tests. In: Egger M., Smith G., and Altman D. (Eds). Systematic reviews in health care: meta-analysis in context. 2nd edn. (2001), BMJ, London 248-282
74. Swets J. Measuring the accuracy of diagnostic systems. Science 240 (1988) 1285-1293
75. Song F., Khan K., Dinnes J., and Sutton A. Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31 (2002) 88-95
76. Boysen A., Madsen J., and Jorgensen P. Procalcitonin as a marker of postoperative complications. Scand J Clin Lab Invest 65 (2005) 387-394
77. Simon L., Gauvin F., Amre D., Saint-Louis P., and Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39 (2004) 206-217
78. Irwig L., Macaskill P., Glaszious P., and Fahey M. Meta-analytical methods for diagnostic test accuracy. J Clin Epidemiol 48 (1995) 119-130
79. Sterne J., Gavaghan D., and Egger M. Publication and related biases in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53 (2000) 1119-1129
80. Irwig L., and Berry G. Graphical test is itself biased. BMJ 316 (1998) 469-569
81. Alberti C., Brun-Buisson C., Goodman S., et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168 (2003) 77-84
82. Abraham E., Matthay M., Dinarello C., et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 28 (2000) 232-235
83. Bone R., Balk R., Cerra F., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
84. Sands K., Bates D., Lanken P., Graman P., et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 277 (1997) 234-240
85. Trzeciak S., Zanotti-Cavazzoni S., Parillo J., and Dellinger R. Inclusion criteria for clinical trials in sepsis: did the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions of Sepsis have an impact?. Chest 127 (2005) 242-245
86. Sprung C., Sakr Y., Vincent J.-L., et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence in Acutely ill Patients (SOAP) study. Intensive Care Med 32 (2006) 421-427